生命科学资讯

FDA floats user fee cuts for early-stage US trials, additional fees for overseas development

Capricor's phase 3 win sets up 2nd approval attempt for Duchenne cell therapy

Olympus-backed robotics startup Swan EndoSurgical taps Stryker vet for CEO

Fierce Biotech Fundraising Tracker '25: Triana glues $120M series B; Protego raises $130M

FDA approves next-gen prostate cancer PSA test from Cleveland Diagnostics

With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis

Pfizer-backed Triana scores $120M series B to take molecular glue degrader into clinic

Janux T-cell engager data sink stock, but analysts still see best-in-class potential

FDA issues draft guidance to reduce primate testing for certain antibodies

Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter

CDER head Richard Pazdur set to retire shortly after appointment

Imvax takes brain cancer cell therapy to FDA, betting survival hit will overshadow primary miss

Tiziana to spin out IL-6 drug into new company, citing Big Pharma's interest in modality

Novocure promotes new CEO, replacing current chief after less than a year

Roche's point-of-care whooping cough test greenlighted in US, Europe as cases surge

FDA adopts agentic AI in latest push to infuse artificial intelligence into agency

Regeneron makes $150M bet on Tessera's rare disease gene writing prospect

European Union teams up with Angelini to funnel €150M to European health startups

Belite brings FDA filing into view with phase 3 Stargardt disease victory

GE HealthCare, Philips, Siemens spotlight AI-forward imaging at RSNA 2025